biomedicina slovenica

pr=Bohanec-Grabar : 17

  1. Bohanec-Grabar Petra; Leandro-Garcia Luis J; Inglada-Perez Lucia; Logar Dušan; Rodriguez-Antona Cristina; Dolžan Vita
    Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients
    2012 ►
  2. Bohanec-Grabar Petra; Rojko Sabina; Logar Dušan; Dolžan Vita
    Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
    2010 ►
  3. Bohanec-Grabar Petra; Rozman Blaž; Logar Dušan; Dolžan Vita
    Pharmacogenetics - a step further towards personalized DMARD treatment of rheumatoid arthritis
    2009 ►
  4. Bohanec-Grabar Petra; Logar Dušan; Tomšič Matija; Rozman Blaž; Dolžan Vita
    Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients
    2009 ►
  5. Bohanec-Grabar P; Logar D; Tomšič M; Rozman B; Dolžan V
    Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis
    2009 ►
  6. Bohanec-Grabar Petra; Grabnar Iztok; Rozman Blaž; Logar Dušan; Tomšič Matija; Šuput Daša; Trdan Tina; Peterlin-Mašič Lucija; Mrhar Aleš; Dolžan Vita
    Investigation of the influence of CYP1A2 and CYP2C19 genetic polymorphism on 2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-butenamide (A77 1726) pharmacokinetics in leflunomide-treated patients with rheumatoid arthritis
    2009 ►
  7. Bohanec-Grabar P; Rozman B; Logar D; Praprotnik S; Dolžan V
    Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arhritis
    2009 ►
  8. Bohanec-Grabar Petra; Grabnar Iztok; Mrhar Aleš; Rozman Blaž; Logar Dušan; Tomšič Matija; Praprotnik Sonja; Dolžan Vita
    Genetic polymorphisms of CYP1A2 and CYP2C19 influence leflunomide treatment in rheumatoid arthritis patients
    2008 ►
  9. Bohanec-Grabar Petra; Logar Dušan; Lestan B; Dolžan Vita
    Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism
    2008 ►
  10. Bohanec-Grabar Petra; Logar Dušan; Tomšič Matija; Rozman Blaž; Dolžan Vita
    Genetic polymorphisms controlling oxidative stress influence the activity of rheumatoid arthritis
    2007 ►
  11. Bohanec-Grabar Petra; Grabnar Iztok; Mrhar Aleš; Rozman Blaž; Logar Dušan; Tomšič Matija; Praprotnik Sonja; Dolžan Vita
    Genetic polymorphisms of CYP1A2 and CYP2C19 influence leflunomide treatment in rheumatoid arthritis patients
    2008 ►
  12. Bohanec-Grabar Petra; Rozman Blaž; Tomšič Matija; Šuput Daša; Logar Dušan; Dolžan Vita
    Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients
    2008 ►
  13. Bohanec-Grabar P; Logar D; Lestan B; Dolžan V
    Genetic polymorphisms in folate metabolic pathway increase the risk for adverse effects during methotrexate treatment in rheumatoid arthritis
    2006 ►
  14. Bohanec-Grabar Petra; Logar Dušan; Lestan Boris; Dolžan Vita
    Genetic polymorphisms in folate metabolic pathway increase the risk for adverse effects during methotrexate treatment in rheumatic arthritis
    2007 ►
  15. Bohanec-Grabar Petra; Rozman Blaž; Logar Dušan; Tomšič Matija; Dolžan Vita
    Genetic polymorphism of CYP1A2 and CYP2C19 and the outcome of leflunomide tratment in rheumatoid arthritis patients
    2007 ►
  16. Bohanec-Grabar Petra; Dolžan Vita; Rodriguez-Antona Cristina
    Role of pharmacogenetics for the improvement of cancer tratment
    [Vloga farmakogenetike pri učinkovitejšem zdravljenju raka]
    2007 ►
  17. Bohanec-Grabar Petra; Logar Dušan; Lestan Boris; Dolžan Vita
    Genetic polymorphisms in folate metabolic pathway influence the risk for developing adverse effects during methotrexate treatment in rheumatoid arthritis
    2007 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics